$3.00
0[0.00%]
Last update: 1:09PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
| Open- | Close- |
| Vol / Avg.0 / 509.000 | Mkt Cap742.350M |
| Day Range- - - | 52 Wk Range2.862 - 17.650 |
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
CanSino Biologics Stock (OTC:CASBF), Key Statistics
CanSino Biologics Stock (OTC: CASBF) analysis, key statistics.
Valuation Measures
Enterprise Value
1.3B
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
12.78
Price / Book (mrq)
0.92
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-32.66%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
3.28
Tangible Book value per share
3.2
Total Liabilities (Quarterly)
3.9B
Total Assets
9.9B
Total Liabilities
3.9B
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -